⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL290786 | 0.81 | — | — | |
| SCHEMBL23532480 | 0.78 | — | — | |
| SCHEMBL5550339 | 0.76 | — | — | |
| SCHEMBL4487319 | 0.75 | — | — | |
| SCHEMBL821115 | 0.75 | — | — | |
| SCHEMBL4487307 | 0.75 | — | — | |
| SCHEMBL5604846 | 0.75 | — | — | |
| SCHEMBL7663751 | 0.75 | — | — | |
| Boric Acid SCHEMBL29031261 | 0.74 | — | — | |
| SCHEMBL1214816 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114591223-A | Beta-lactamase inhibitor compounds | 恩塔西斯治疗有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-109715630-B | Beta-lactamase inhibitor compounds | 恩塔西斯治疗有限公司 | 2022-02-22 | — | — | CN | disclosed |